2m 2m 2m 2m 2m 2m 2m
CONMED CORP (CNMD)
NYSE
$33.11-$0.75 (-2.20%)
Price as of Jun 03, 2026 5:00 PM EDT- $1.1BMarket Cap
- -40.08%1-Year Change
- Medical DevicesIndustry
CONMED CORP (CNMD)
$33.11-$0.75 (-2.20%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4B +5.18% | 1.3B +5.00% | 1.2B +19.06% | 1.0B +3.45% | |
Cost of Revenue | 624.2M +8.76% | 574.0M +0.96% | 568.5M +19.88% | 474.2M +7.15% | |
Gross Profit | 750.5M +2.38% | 733.0M +8.40% | 676.2M +18.38% | 571.2M +0.56% | |
Sales and Marketing Expense | 592.0M +23.77% | 478.3M -4.92% | 503.0M +10.79% | 454.0M +9.47% | |
Research and Development Expense | -55.9M +2.68% | -54.4M +3.47% | -52.6M +11.56% | -47.2M +8.23% | |
Depreciation and Amortization Expense | 17.1M +3.24% | 16.6M +2.50% | 16.2M +0.90% | 16.1M -2.66% | |
Total Operating Expenses | 647.9M +21.62% | 532.7M -4.13% | 555.6M +10.86% | 501.2M +9.35% | |
Operating Profit | 102.6M -48.77% | 200.3M +66.10% | 120.6M +72.16% | 70.1M -36.15% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -31.1M -16.65% | -37.3M -6.23% | -39.8M +37.61% | -28.9M -18.54% | |
Interest Income and Expense and Net | -31.1M -16.65% | -37.3M -6.23% | -39.8M +37.61% | -28.9M -18.54% | |
Total Nonoperating Income and Expense | 31.1M -16.65% | 37.3M -6.23% | 39.8M +37.61% | 28.9M -18.54% | |
Income before Taxes | 71.1M -56.38% | 163.0M +101.70% | 80.8M +214.06% | -70.9M -196.93% | |
Income Taxes | 24.1M -21.38% | 30.6M +86.98% | 16.4M +68.41% | 9.7M -7.98% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 47.1M -64.47% | 132.4M +105.44% | 64.5M +179.99% | -80.6M -228.84% | |
Net Income from Continuing Operations Applicable to Common | 71.1M -56.38% | 163.0M +101.70% | 80.8M +214.06% | -70.9M -196.93% | |
Basic EPS and Net Income | 1.52 -64.57% | 4.29 +104.29% | 2.10 +178.36% | -2.68 -225.23% | |
Diluted EPS and Net Income | 1.51 -64.47% | 4.25 +108.33% | 2.04 +176.12% | -2.68 -238.14% | |
Basic Weighted Average Shares | 31.0M +0.62% | 30.8M +0.58% | 30.7M +2.09% | 30.0M +3.01% | |
Diluted Weighted Average Shares | 31.1M -0.003% | 31.1M -1.26% | 31.5M +5.02% | 30.0M -6.75% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 40.8M +66.88% | 24.5M +0.67% | 24.3M -16.05% | 28.9M +38.83% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 40.8M +66.88% | 24.5M +0.67% | 24.3M -16.05% | 28.9M +38.83% | |
Total Current Assets | 672.9M +5.13% | 640.0M +3.96% | 615.6M +5.92% | 581.2M +26.32% | |
Accumulated Depreciation | 316.6M +3.67% | 305.4M +4.54% | 292.2M +5.27% | 277.5M +5.22% | |
Property and Plant and Equipment and Net | 113.3M -2.13% | 115.8M -4.08% | 120.7M +4.42% | 115.6M +6.20% | |
Total Long-Term Assets | 137.2M +17.90% | 116.4M +21.07% | 96.1M +2.38% | 93.9M -4.98% | |
Total Assets | 2.3B +0.85% | 2.3B +0.27% | 2.3B +0.11% | 2.3B +30.10% | |
Income Taxes Payable | 79.5M +7.36% | 74.1M +21.63% | 60.9M -8.73% | 66.7M -2.64% | |
Total Short-Term Debt | 712,000 -0.42% | 715,000 +0.99% | 708,000 -98.98% | 69.7M +469.40% | |
Total Current Liabilities | 315.0M +13.27% | 278.1M -10.49% | 310.7M +4.78% | 296.6M +50.80% | |
Total Long-Term Debt | 834.2M -7.83% | 905.1M -7.00% | 973.1M -1.21% | 985.1M +46.50% | |
Total Long-Term Liabilities | 63.9M -26.01% | 86.3M -28.70% | 121.0M -40.58% | 203.7M +373.80% | |
Total Liabilities | 1.3B -3.79% | 1.3B -8.34% | 1.5B -5.56% | 1.6B +58.28% | |
Retained Earnings | 588.8M +5.08% | 560.3M +23.81% | 452.5M +9.67% | 412.6M -16.91% | |
Total Stockholders Equity | 1.0B +7.31% | 962.7M +15.40% | 834.2M +11.89% | 745.5M -5.08% | |
Total Shares Outstanding | 31.3M 0.00% | 31.3M 0.00% | 31.3M 0.00% | 31.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 170.7M +2.23% | 167.0M +33.20% | 125.3M +275.69% | 33.4M -70.15% | |
Capital Expenditures | 19.8M +51.38% | 13.1M -31.25% | 19.0M -12.64% | 21.8M +46.54% | |
Cash from Investing Activities | -21.0M +60.17% | -13.1M -34.68% | -20.0M -91.97% | -249.5M +1,578.52% | |
Dividends Paid | 24.7M +0.39% | 24.7M +0.61% | 24.5M +2.26% | 24.0M +3.03% | |
Cash from Financing Activities | -135.8M -10.05% | -151.0M +36.74% | -110.4M -149.08% | 225.0M +321.57% | |
Financials Ratio | |||||
Gross Margin | 54.59% -2.66% | 56.08% +3.23% | 54.33% -0.57% | 54.64% -2.79% | |
Operating Margin | 7.46% -51.30% | 15.33% +58.19% | 9.69% +44.60% | 6.70% -38.28% | |
Return on Assets | 2.03% -64.66% | 5.75% +105.05% | 2.80% +170.70% | -3.97% -211.53% | |
Return on Equity | 4.72% -68.01% | 14.74% +80.61% | 8.16% +177.52% | -10.53% -225.77% | |
Revenue Growth | 5.18% +3.55% | 5.00% -73.75% | 19.06% +452.96% | 3.45% -79.94% | |
Current Ratio | 2.14 -7.18% | 2.30 +16.14% | 1.98 +1.09% | 1.96 -16.24% | |
Cash Ratio | 0.13 +47.44% | 0.09 +12.40% | 0.08 -19.88% | 0.10 -7.92% | |
Debt-to-Equity Ratio | 0.81 -14.10% | 0.94 -19.40% | 1.17 -17.49% | 1.41 +62.30% | |
Debt-to-Assets Ratio | 0.36 -8.60% | 0.39 -7.23% | 0.42 -7.78% | 0.46 +18.42% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow